AI helping us make smarter, faster decisions, says Novartis R&D chiefNovartis is trialling artificial intelligence (AI) in settings across drug discovery and drug development to help its scientists Share XAI helping us make smarter, faster decisions, says Novartis R&D chiefhttps://pharmaphorum.com/news/ai-helping-us-says-novartis-rd-chief/
2016 saw slump in FDA drug approvals, but 2017 could be return to formFDA approvals could rebound in 2017 – but concerns about big pharma R&D productivity won’t go away. Share X2016 saw slump in FDA drug approvals, but 2017 could be return to formhttps://pharmaphorum.com/views-and-analysis/2016-saw-slump-fda-drug-approvals-2017-return-form/